Background HAQ score is a major index of rheumatoid arthritis (RA) disease severity in clinical practice. Data indicate that patients with RA and high HAQ scores (>2) receive disability benefits (1). We investigated the proportion of patients with no and severe disability (HAQ>2) (2,3) during the era of biologic therapies in a large international database. This query provides “real world” data about the burden of disability associated with RA in different clinical settings and in different cohorts.
Objectives To assess the proportions of RA patients with no and severe disability across various countries.
Methods The METEOR database is an international database that has recruited RA patients from different countries who are followed in the setting of usual care at various centres. We report the number of patients in this database (Table 1) and we analyzed the proportion of RA patients for whom all values have been entered, considering the different characteristics across participating countries.
Conclusions This cross-sectional study suggests that, especially in the UK and Italy, RA patients with HAQ scores<0.5 at entry into the database are in the minority and that there remains a not insignificant number of subjects with a HAQ score >2. This suggests that there may still be an opportunity to treat RA more aggressively in some countries. Further studies are warranted to determine whether this reflects barriers to successful treatment of RA that may be inherent in some health care systems or if it is merely an indication of structural damage from past disease activity.
Kirwan J et al. British J of Rheum 1986; 25:206-209
Krishnan E et al. Arth Rheum 2004; 50: 953-960
Mancarella L et al. J Rheumatol 2007; 34:1670-1673
Disclosure of Interest None Declared